Learn More
Invitrogen™ LSP1 Recombinant Rabbit Monoclonal Antibody (SN06-25)

Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | LSP1 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | SN06-25 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 40% Glycerol, 0.05% BSA and 0.05% sodium azide; pH 7.4 |
| Gene | LSP1 |
| Gene Accession No. | P19973, P33241 |
| Gene Alias | 1 BAC CH230-300K22 (Children's Hospital Oakland Research Institute) complete; 47 kDa actin binding protein; 47 kDa actin-binding protein; 52 kDa phosphoprotein; F-actin binding and cytoskeleton associated protein; leufactin (leukocyte F-actin binding protein); leukocyte specific protein 1; leukocyte-specific protein 1; lsp; LSP1; Lsp-1; lymphocyte specific 1; lymphocyte specific protein 1; lymphocyte-specific antigen WP34; Lymphocyte-specific protein 1; OTTHUMP00000014138; OTTHUMP00000069614; OTTHUMP00000069615; OTTHUMP00000069616; p50; pp52; S37; S37 protein; WP34 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.